Lawrence Keusch is the Vice President of Investor Relations and Strategy Development at Teleflex. Prior to joining Teleflex, Keusch worked for Goldman Sachs for 21 years, where they were a managing director and sector leader for global medical device investment research. While at Goldman Sachs, Keusch was responsible for covering 20 U.S. medical device stocks in cardiology/vascular, ophthalmology, orthopedics, and diversified hospital supplies. Lawrence also advised institutional investors on equity asset allocation and participated in more than 40 public offerings and M&A transactions.
Lawrence Keusch studied biology at Tufts University, earning a Bachelor's Degree in the subject. Lawrence then went on to complete a medical degree and become a doctor.
Lawrence Keusch works with Michael Kryukov - Vice President, Global Tax, Howard Cyr - Corporate VP and Chief Compliance Officer, and Matthew James - President, EMEA and Global Urology. Lawrence Keusch reports to Liam J. Kelly, Chairman, President & CEO.
Current role